| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Indoleamine 2,3-dioxygenase 1 |
|---|
| Ligand | BDBM50538500 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2035521 (CHEMBL4689679) |
|---|
| IC50 | 9.6±n/a nM |
|---|
| Citation |  Li, D; Deng, Y; Achab, A; Bharathan, I; Hopkins, BA; Yu, W; Zhang, H; Sanyal, S; Pu, Q; Zhou, H; Liu, K; Lim, J; Fradera, X; Lesburg, CA; Lammens, A; Martinot, TA; Cohen, RD; Doty, AC; Ferguson, H; Nickbarg, EB; Cheng, M; Spacciapoli, P; Geda, P; Song, X; Smotrov, N; Abeywickrema, P; Andrews, C; Chamberlin, C; Mabrouk, O; Curran, P; Richards, M; Saradjian, P; Miller, JR; Knemeyer, I; Otte, KM; Vincent, S; Sciammetta, N; Pasternak, A; Bennett, DJ; Han, Y Carbamate and ACS Med Chem Lett12:389-396 (2021) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Indoleamine 2,3-dioxygenase 1 |
|---|
| Name: | Indoleamine 2,3-dioxygenase 1 |
|---|
| Synonyms: | I23O1_HUMAN | IDO | IDO-1 | IDO1 | INDO | Indoleamine 2,3-Dioxygenasae (IDO) | Indoleamine 2,3-dioxygenase | Indoleamine-pyrrole 2,3-dioxygenase |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 45330.80 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P14902 |
|---|
| Residue: | 403 |
|---|
| Sequence: | MAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVE
KLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLEL
PPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKV
IPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGN
PQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMP
PAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQ
QPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG
|
|
|
|---|
| BDBM50538500 |
|---|
| n/a |
|---|
| Name | BDBM50538500 |
|---|
| Synonyms: | CHEMBL4636709 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C21H23ClN2O2 |
|---|
| Mol. Mass. | 370.873 |
|---|
| SMILES | CCCNC(=O)C1(CCC1)c1ccc(NC(=O)c2cccc(Cl)c2)cc1 |
|---|
| Structure | 
|
|---|
Search and Browse
